Harvard Bioscience (HBIO) Share-based Compensation (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Share-based Compensation of $2.2 million for Q1 2026, up 2833.33% year-over-year from $75000.0 in Q1 2025, and up 379.3% quarter-over-quarter from $459000.0 in Q4 2025.
Harvard Bioscience (HBIO) Share-based Compensation (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Share-based Compensation for 17 consecutive years, with $2.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation rose 2833.33% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (up 192.32% YoY), while the FY2025 annual figure was $1.9 million, down 54.76% from the prior year.
- Share-based Compensation grew to $2.2 million in Q1 2026 per HBIO's latest filing, from $459000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $2.2 million in Q2 2025 and bottomed at -$3.4 million in Q4 2024.
- Historically, Share-based Compensation has averaged $572058.8 across 5 years, with a median of $704000.0 in 2023.
- Annual changes were most pronounced in 2024 — Share-based Compensation tumbled 649.22% — and 2026, when it surged 2833.33%.
- Harvard Bioscience's Share-based Compensation stood at $1.5 million in 2022, then plunged by 129.44% to -$451000.0 in 2023, then sank by 649.22% to -$3.4 million in 2024, then jumped by 113.58% to $459000.0 in 2025, then soared by 379.3% to $2.2 million in 2026.
- Business Quant data shows HBIO's Share-based Compensation at $2.2 million in Q1 2026, $459000.0 in Q4 2025, and $18000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 67.10 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 55.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 42.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 27.46 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 29.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 38.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 33.00 Mn |
| 10 | Harvard Bioscience | 34.12 Mn | 27.61 Mn | 12.63 Mn | 2.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.30 Mn |
| Jun 30, 2026 | 2.30 Mn |
| Mar 31, 2026 | 2.20 Mn |
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | 459,000.00 |
| Dec 31, 2025 | 459,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Jun 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Mar 31, 2025 | 75,000.00 |
| Mar 31, 2025 | 75,000.00 |
| Dec 31, 2024 | -3.38 Mn |
| Dec 31, 2024 | -3.38 Mn |
| Sep 30, 2024 | 795,000.00 |
| Sep 30, 2024 | 795,000.00 |
| Jun 30, 2024 | 126,000.00 |
| Jun 30, 2024 | 126,000.00 |
| Mar 31, 2024 | 1.05 Mn |
| Mar 31, 2024 | 1.05 Mn |